510(k) Reform Debate: Class IIb Or Not To Be?
This article was originally published in The Gray Sheet
Executive Summary
As FDA prepares to announce planned 510(k) program reforms in the coming weeks, a key question is what will become of the proposal to split up Class II devices into two distinct categories.
You may also be interested in...
Insulin Pump Standards: Confusion Persists Over Pre-Market Requirements
Companies say FDA is asking for clinical data where it has not in the past and that new standards appear to have been established for the devices, but FDA insists no new clinical requirements have been implemented and that insulin pumps are not being singled out.
Insulin Pump Standards: Confusion Persists Over Pre-Market Requirements
Some companies in the insulin pump arena say FDA is asking for clinical data where it has not done so in the past and that new standards appear to have been established for the devices.
Insulin Pump Standards: Confusion Persists Over Pre-Market Requirements
Some companies in the insulin pump arena say FDA is asking for clinical data where it has not done so in the past and that new standards appear to have been established for the devices.